Epirubicin

Back to search

Molecule Structure

Scientific Name

Epirubicin

Description of the Drug

Epirubicin is an anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00445

Brand Name(s)

Not Available

Company Owner(s)

Actavis Totowa Llc, Impax Laboratories Inc, West-Ward Pharmaceuticals International Ltd, Fresenius Kabi Usa Llc, Hospira Inc, Pfizer Inc, Ebewe Pharma Ges Mbh Nfg Kg, Mylan Institutional Llc, Zennova Pharmaceuticals Chengdu Co Ltd, Akorn Operating Co Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

SureChEMBL SCHEMBL8582
PharmGKB PA449476
Human Metabolome Database HMDB0014588
WDI EPIRUBICI
DrugBank DB00445
PubChem: Thomson Pharma 14837077 14812446
PubChem 41867
LINCS LSM-2078
Nikkaji J81.933F
BindingDB 43839
EPA CompTox Dashboard DTXSID0022987
DrugCentral 1030
Metabolights MTBLC47898
GSRS 4f0a4a62-6657-47f4-b12d-9726d36e34c2
rxnorm EPIRUBICIN EPIRUBICIN HYDROCHLORIDE ELLENCE
KEGG Ligand C11230
ChEBI 47898
ZINC ZINC000003938704